Keyphrases
IgG4-related Disease (IgG4-RD)
100%
Autoimmune Disease
73%
Giant Cell Arteritis
66%
Poor Prognosis
66%
COVID-19
52%
Systemic Lupus Erythematosus
48%
Multiple Sclerosis
40%
Immunosuppressive Therapy
39%
COVID-19 Patients
36%
Adverse Impact
33%
CT Findings
33%
Neuropsychiatric Systemic Lupus Erythematosus (NPSLE)
33%
TNF Superfamily
33%
Functional Variants
33%
BRAFV600
33%
Erdheim-Chester Disease
33%
Severe Acute Respiratory Syndrome coronavirus-2 Vaccine
33%
COVID-19 Pneumonia
33%
EScreening
33%
Ductular Reaction
33%
Chest X-ray
33%
Myo-inositol
33%
MTOR Inhibitor
33%
Acute Hepatitis E
33%
Histology
33%
Myelodysplastic Syndrome
33%
Vemurafenib
33%
Predisposing Factors
33%
Neurological Manifestations
33%
Anti-ganglioside Antibodies
33%
Transaminase Levels
33%
Predictive Models
33%
Amyloidosis
33%
Survival Prediction
33%
Cellular Response
33%
MR Spectroscopy
33%
Langerhans Cell Histiocytosis
33%
Gray Matter
33%
Male Patients
33%
Interleukin-6
33%
Immune Impairment
33%
Systemic Sclerosis
33%
Anti-CD20
33%
Patients with COVID-19
33%
Advanced Liver Disease
33%
Humoral Response
33%
Ischemic Events
33%
Idiopathic Retroperitoneal Fibrosis
33%
Serum Testosterone
33%
Testosterone
33%
Medicine and Dentistry
COVID-19
66%
Immunoglobulin G4
55%
Biological Marker
52%
Severe Acute Respiratory Syndrome Coronavirus 2
51%
Diseases
49%
Autoimmune Disease
44%
Systemic Lupus Erythematosus
41%
Positron Emission Tomography-Computed Tomography
41%
Immunity
38%
IgG4-Related Disease
36%
Multiple Sclerosis
33%
Immunoglobulin G4 Related Disease
33%
Amyloidosis
33%
Ganglioside Antibody
33%
Retroperitoneal Fibrosis
33%
Liver Disease
33%
Erdheim-Chester Disease
33%
Vemurafenib
33%
Langerhans Cell Histiocytosis
33%
CD20
33%
Inositol
33%
Neurologic Finding
33%
Gray Matter
33%
Lupus Erythematosus
33%
Immunosuppressive Treatment
33%
Disease Predisposition
33%
Hepatitis E Virus
33%
Chronic Hepatitis
33%
Hepatitis E
33%
Transaminase
33%
Mammalian Target of Rapamycin Inhibitor
33%
Autoimmune Hepatitis
33%
Giant-Cell Arteritis
33%
NMR Spectroscopy
33%
Diagnosis
28%
Sphingosine 1 Phosphate Receptor
25%
Thorax Radiography
25%
Interleukin 6
25%
Fibrosis
22%
Vertebral Artery
22%
Rituximab
19%
Immunoglobulin M
17%
Ferritin
16%
Fibril
16%
Magnetic Resonance Imaging
16%
Amyloid Protein
16%
Retrospective Study
16%
Liver Cirrhosis
15%
Chronic Kidney Disease
14%
middle age
13%
Immunology and Microbiology
Autoimmune Disease
84%
Immunoglobulin G4 Related Disease
69%
Immunoglobulin G4
55%
Severe Acute Respiratory Syndrome Coronavirus 2
41%
Multiple Sclerosis
40%
Immunosuppressive Drug
36%
Immunity
36%
Hepatitis E Virus
33%
Lupus Erythematosus
33%
Hepatitis E
33%
Magnetic Resonance Imaging
33%
Tumor Necrosis Factor
33%
White Matter
33%
Systemic Scleroderma
33%
COVID-19
33%
Gray Matter
33%
Autoimmune Hepatitis
33%
Giant Cell Arteritis
33%
CD20
33%
Interleukin 6
25%
Immunosuppressive Therapy
25%
Systemic Lupus Erythematosus
23%
Rituximab
19%
B Cell
17%
Central Nervous System
16%
Metabolite
16%
Ferritin
16%
Temporal Cortex
16%
Cytokine
13%
B Cell Activating Factor
13%
Innate Immune System
11%
Adaptive Immune System
11%
Infectious Agent
11%
T Cell
11%
Cell Count
11%
Phlebitis
11%
Prevalence
8%
Immunology
8%
Humoral Immunity
8%
Analytical Parameters
8%
Salivary Gland
8%
Pancreas
8%
Platelet
8%
Lymph Node
8%
Inflammatory Arthritis
6%
Genetic Variability
6%
Genetic Risk
6%
Single Nucleotide Polymorphism
6%
Autoimmunity
6%
Allele
6%
